In this webinar, we explore intoxicating hemp and synthetic cannabinoids have permeated the cannabis market, but there are not many regulatory requirements for production and product testing.
The GMP Collective kicked off 2024 with a fresh webinar episode of When Things Go Wrong by dissecting the nuances between hemp-derived and synthetic cannabinoids including THCa, THCP, Delta-8, Delta-9, and more.
In this episode, we delved into lab testing issues in the cannabis industry, including lab shopping and THC inflation. We highlighted the need for a new perspective on flower potency testing and the importance of representative sampling. We also discussed the misconceptions about THC content and quality, and the complexities of CRM shopping, measurement uncertainty, and shelf stability.
In this webinar, we explore intoxicating hemp and synthetic cannabinoids have permeated the cannabis market, but there are not many regulatory requirements for production and product testing.
The GMP Collective kicked off 2024 with a fresh webinar episode of When Things Go Wrong by dissecting the nuances between hemp-derived and synthetic cannabinoids including THCa, THCP, Delta-8, Delta-9, and more.
In this episode, we delved into lab testing issues in the cannabis industry, including lab shopping and THC inflation. We highlighted the need for a new perspective on flower potency testing and the importance of representative sampling. We also discussed the misconceptions about THC content and quality, and the complexities of CRM shopping, measurement uncertainty, and shelf stability.